Smith Salley Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35M | Buy |
160,791
+3,415
| +2% | +$758K | 1.76% | 14 |
|
|
2025
Q4 | $36M | Sell |
157,376
-1,541
| -1% | -$351K | 1.78% | 12 |
|
|
2025
Q3 | $36.8M | Buy |
158,917
+4,911
| +3% | +$1M | 1.89% | 12 |
|
|
2025
Q2 | $28.6M | Buy |
154,006
+3,083
| +2% | +$573K | 1.65% | 14 |
|
|
2025
Q1 | $31.6M | Sell |
150,923
-19,257
| -11% | -$3.74M | 2.07% | 11 |
|
|
2024
Q4 | $30.2M | Buy |
170,180
+1,383
| +0.8% | +$254K | 1.94% | 12 |
|
|
2024
Q3 | $33.3M | Buy |
168,797
+3,548
| +2% | +$662K | 2.18% | 9 |
|
|
2024
Q2 | $28.3M | Buy |
165,249
+8,245
| +5% | +$1.37M | 2.03% | 9 |
|
|
2024
Q1 | $28.6M | Sell |
157,004
-53,544
| -25% | -$9.23M | 2.22% | 9 |
|
|
2023
Q4 | $32.6M | Buy |
210,548
+3,815
| +2% | +$556K | 2.11% | 10 |
|
|
2023
Q3 | $30.8M | Buy |
206,733
+5,935
| +3% | +$871K | 2.29% | 8 |
|
|
2023
Q2 | $27.1M | Buy |
200,798
+949
| +0.5% | +$139K | 2% | 11 |
|
|
2023
Q1 | $31.8M | Buy |
199,849
+5,145
| +3% | +$787K | 2.53% | 4 |
|
|
2022
Q4 | $31.5M | Buy |
194,704
+889
| +0.5% | +$136K | 2.69% | 4 |
|
|
2022
Q3 | $26M | Buy |
193,815
+1,337
| +0.7% | +$192K | 2.42% | 5 |
|
|
2022
Q2 | $29.5M | Buy |
192,478
+5,945
| +3% | +$908K | 2.55% | 4 |
|
|
2022
Q1 | $30.2M | Sell |
186,533
-42,408
| -19% | -$6.16M | 2.28% | 6 |
|
|
2021
Q4 | $31M | Buy |
228,941
+2,325
| +1% | +$275K | 2.2% | 8 |
|
|
2021
Q3 | $24.4M | Buy |
226,616
+4,427
| +2% | +$506K | 1.92% | 12 |
|
|
2021
Q2 | $25M | Buy |
222,189
+207
| +0.1% | +$23.3K | 2.03% | 10 |
|
|
2021
Q1 | $24M | Buy |
221,982
+6,615
| +3% | +$708K | 2.16% | 10 |
|
|
2020
Q4 | $23.1M | Buy |
215,367
+17,762
| +9% | +$1.71M | 2.34% | 6 |
|
|
2020
Q3 | $17.3M | Buy |
197,605
+609
| +0.3% | +$57.3K | 2.09% | 10 |
|
|
2020
Q2 | $19.3M | Sell |
196,996
-3,451
| -2% | -$304K | 2.58% | 4 |
|
|
2020
Q1 | $15.3M | Buy |
200,447
+7,483
| +4% | +$637K | 2.54% | 8 |
|
|
2019
Q4 | $17.1M | Sell |
192,964
-266
| -0.1% | -$22.1K | 2.25% | 7 |
|
|
2019
Q3 | $14.6M | Buy |
193,230
+17,698
| +10% | +$1.21M | 2.08% | 12 |
|
|
2019
Q2 | $12.8M | Buy |
175,532
+51,846
| +42% | +$4.08M | 1.92% | 11 |
|
|
2019
Q1 | $9.97M | Buy |
123,686
+6,936
| +6% | +$567K | 1.6% | 17 |
|
|
2018
Q4 | $10.8M | Buy |
116,750
+2,033
| +2% | +$179K | 1.98% | 9 |
|
|
2018
Q3 | $10.8M | Buy |
114,717
+2,862
| +3% | +$271K | 1.71% | 15 |
|
|
2018
Q2 | $10.4M | Buy |
111,855
+22,716
| +25% | +$2.22M | 1.77% | 14 |
|
|
2018
Q1 | $8.44M | Buy |
89,139
+947
| +1% | +$104K | 1.51% | 20 |
|
|
2017
Q4 | $8.53M | Buy |
88,192
+1,201
| +1% | +$113K | 1.53% | 18 |
|
|
2017
Q3 | $7.73M | Sell |
86,991
-29,629
| -25% | -$2.26M | 1.48% | 18 |
|
|
2017
Q2 | $8.46M | Sell |
116,620
-267
| -0.2% | -$17.9K | 1.7% | 12 |
|
|
2017
Q1 | $7.62M | Sell |
116,887
-3,505
| -3% | -$220K | 1.56% | 17 |
|
|
2016
Q4 | $7.54M | Sell |
120,392
-175
| -0.1% | -$10.7K | 1.57% | 18 |
|
|
2016
Q3 | $7.6M | Buy |
120,567
+1,123
| +0.9% | +$72.7K | 1.69% | 16 |
|
|
2016
Q2 | $7.39M | Buy |
119,444
+6,835
| +6% | +$416K | 1.72% | 16 |
|
|
2016
Q1 | $6.43M | Buy |
112,609
+22,010
| +24% | +$1.23M | 1.61% | 18 |
|
|
2015
Q4 | $5.37M | Buy |
90,599
+2,582
| +3% | +$149K | 1.34% | 27 |
|
|
2015
Q3 | $4.79M | Buy |
88,017
+1,958
| +2% | +$127K | 1.29% | 29 |
|
|
2015
Q2 | $5.78M | Buy |
86,059
+3,946
| +5% | +$258K | 1.47% | 21 |
|
|
2015
Q1 | $4.81M | Buy |
82,113
+7,346
| +10% | +$444K | 1.23% | 31 |
|
|
2014
Q4 | $4.89M | Buy |
74,767
+5,072
| +7% | +$320K | 1.27% | 28 |
|
|
2014
Q3 | $4.03M | Buy |
69,695
+2,287
| +3% | +$127K | 1.07% | 31 |
|
|
2014
Q2 | $3.81M | Buy |
67,408
+24,650
| +58% | +$1.29M | 1.02% | 29 |
|
|
2014
Q1 | $2.2M | Buy |
42,758
+149
| +0.3% | +$7.53K | 1.37% | 28 |
|
|
2013
Q4 | $2.25M | Sell |
42,609
-259
| -0.6% | -$12.7K | 1.47% | 28 |
|
|
2013
Q3 | $1.92M | Buy |
42,868
+1,498
| +4% | +$66.4K | 1.54% | 30 |
|
|
2013
Q2 | $1.71M | Buy |
+41,370
| New | +$1.81M | 1.38% | 33 |
|
Other funds holding ABBV
VCM
VPM
Smith Salley Wealth Management's ABBV Position: Q1 2026 in Review
Smith Salley Wealth Management increased its AbbVie (ABBV) stake by 2.2% in Q1 2026, buying an estimated $758K and bringing the position to 160,791 shares worth $35M. The position accounts for 1.76% of the portfolio, ranked #14.
Smith Salley Wealth Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $36.8M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Smith Salley Wealth Management held 160,791 shares of AbbVie worth $35M as of Q1 2026.
- Smith Salley Wealth Management bought 3,415 AbbVie shares in Q1 2026, an estimated $758K.
- AbbVie made up 1.76% of Smith Salley Wealth Management's portfolio in Q1 2026, its #14 holding.
- Smith Salley Wealth Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Smith Salley Wealth Management's AbbVie position peaked at $36.8M in Q3 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Smith Salley Wealth Management's 13F filing for Q1 2026, filed 16 Apr 2026.